Molecular model of a monoclonal antibody Nivolumab fragment with the light (red) and heavy chain (blue). Nivolumab, a human IgG4 monoclonal antibody that blocks PD-1, is an anti-cancer medication used to treat a number of types of cancer. It is a type of immunotherapy and works as a checkpoint inhibitor, blocking a signal that prevents activation of T cells from attacking the cancer.